Learn More
BACKGROUND Oral contraception (OC) and postmenopausal hormone therapy (HT) can be used to alleviate menopausal symptoms. However, the risk of venous thrombosis (VT) associated with OC use in women(More)
F5 R506Q (factor V Leiden) and F2 G20210A (prothrombin G20210A) are risk factors for venous thrombosis (Lijfering et al, 2010). The results of studies as to whether these mutations also increase the(More)